Faculty of Life Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, UK.
Department of Immunology and Medical Genetics, School of Medicine, University of Split, Soltanska 2, Split 21000, Croatia.
J Cell Sci. 2015 Sep 1;128(17):3187-96. doi: 10.1242/jcs.165209. Epub 2015 Jul 13.
Rpn13 is an intrinsic ubiquitin receptor of the 26S proteasome regulatory subunit that facilitates substrate capture prior to degradation. Here we show that the C-terminal region of Rpn13 binds to the tetratricopeptide repeat (TPR) domain of SGTA, a cytosolic factor implicated in the quality control of mislocalised membrane proteins (MLPs). The overexpression of SGTA results in a substantial increase in steady-state MLP levels, consistent with an effect on proteasomal degradation. However, this effect is strongly dependent upon the interaction of SGTA with the proteasomal component Rpn13. Hence, overexpression of the SGTA-binding region of Rpn13 or point mutations within the SGTA TPR domain both inhibit SGTA binding to the proteasome and substantially reduce MLP levels. These findings suggest that SGTA can regulate the access of MLPs to the proteolytic core of the proteasome, implying that a protein quality control cycle that involves SGTA and the BAG6 complex can operate at the 19S regulatory particle. We speculate that the binding of SGTA to Rpn13 enables specific polypeptides to escape proteasomal degradation and/or selectively modulates substrate degradation.
Rpn13 是 26S 蛋白酶体调节亚基的固有泛素受体,可促进降解前底物的捕获。在这里,我们表明 Rpn13 的 C 末端区域与 SGTA 的四肽重复 (TPR) 结构域结合,SGTA 是一种胞质因子,参与错误定位的膜蛋白 (MLP) 的质量控制。SGTA 的过表达导致稳态 MLP 水平显著增加,与对蛋白酶体降解的影响一致。然而,这种效应强烈依赖于 SGTA 与蛋白酶体成分 Rpn13 的相互作用。因此,Rpn13 的 SGTA 结合区域的过表达或 SGTA TPR 结构域内的点突变都抑制了 SGTA 与蛋白酶体的结合,并显著降低了 MLP 水平。这些发现表明,SGTA 可以调节 MLPs 进入蛋白酶体的蛋白水解核心的能力,这意味着涉及 SGTA 和 BAG6 复合物的蛋白质质量控制循环可以在 19S 调节颗粒上发挥作用。我们推测,SGTA 与 Rpn13 的结合使特定多肽能够逃避蛋白酶体降解和/或选择性地调节底物降解。